Aggeletopoulou I, Pantzios S, Triantos C (2025) Personalized immunity: neoantigen-based vaccines revolutionizing hepatocellular carcinoma treatment. Cancers (Basel) 17:376. https://doi.org/10.3390/cancers17030376

Article  CAS  PubMed  Google Scholar 

Ahmad S, Bano N, Khanna K et al (2024) Reporting multitargeted potency of Tiaprofenic acid against lung cancer: molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies. Int J Biol Macromol 276:133872. https://doi.org/10.1016/j.ijbiomac.2024.133872

Article  CAS  PubMed  Google Scholar 

Al Musaimi O, AlShaer D, de la Torre BG, Albericio F (2025) 2024 FDA TIDES (peptides and oligonucleotides) harvest. Pharmaceuticals 18:291. https://doi.org/10.3390/ph18030291

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Sahlawi F, Yaseen Mahmood Alabdali A, Chinnappan S et al (2024) Polymer-based nanoparticles in targeted cancer therapy: a review. J Appl Pharm Sci. https://doi.org/10.7324/JAPS.2024.172227

Article  Google Scholar 

Albertini B, Mathieu V, Iraci N et al (2019) Tumor targeting by Peptide-Decorated gold nanoparticles. Mol Pharm 16:2430–2444. https://doi.org/10.1021/acs.molpharmaceut.9b00047

Article  CAS  PubMed  Google Scholar 

Alonezi S, Tusiimire J, Wallace J et al (2017) Metabolomic profiling of the synergistic effects of melittin in combination with cisplatin on ovarian cancer cells. Metabolites 7:14. https://doi.org/10.3390/metabo7020014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amin M, Badiee A, Jaafari MR (2013) Improvement of pharmacokinetic and antitumor activity of pegylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas. Int J Pharm 458:324–333. https://doi.org/10.1016/j.ijpharm.2013.10.018

Article  CAS  PubMed  Google Scholar 

Annett S, Moore G, Short A et al (2020) FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer. Br J Cancer 122:361–371. https://doi.org/10.1038/s41416-019-0649-5

Article  CAS  PubMed  Google Scholar 

Armstrong GR, Khot MI, Portal C et al (2022) A novel fluorescent c-met targeted imaging agent for intra-operative colonic tumour mapping: translation from the laboratory into a clinical trial. Surg Oncol 40:101679. https://doi.org/10.1016/j.suronc.2021.101679

Article  PubMed  Google Scholar 

Banerji U, Spencer-Briggs DJ, Leslie SA (2023) Phase I/IIa trial of BT1718 in patients with advanced solid tumours. http://isrctn.com/

Baun C, Naghavi-Behzad M, Hildebrandt MG et al (2024) Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review. Semin Nucl Med 54:256–269. https://doi.org/10.1053/j.semnuclmed.2024.01.004

Article  PubMed  Google Scholar 

Beheshti M, Taimen P, Kemppainen J et al (2023) Value of 68Ga-labeled Bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI-a phase I/II study. Eur Radiol 33:472–482. https://doi.org/10.1007/s00330-022-08982-2

Article  CAS  PubMed  Google Scholar 

Binkowski TA, Marino SR, Joachimiak A (2012) Predicting HLA class I non-permissive amino acid residues substitutions. PLoS One 7:e41710. https://doi.org/10.1371/journal.pone.0041710

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bockorny B, Semenisty V, Macarulla T et al (2020) BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial. Nat Med 26:878–885. https://doi.org/10.1038/s41591-020-0880-x

Article  CAS  PubMed  Google Scholar 

Boohaker J, Lee RW, Vishnubhotla M P, et al (2012) The use of therapeutic peptides to target and to kill cancer cells. Curr Med Chem 19:3794–3804. https://doi.org/10.2174/092986712801661004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braun DA, Moranzoni G, Chea V et al (2025) A neoantigen vaccine generates antitumour immunity in renal cell carcinoma. Nature 639:474–482. https://doi.org/10.1038/s41586-024-08507-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown NF, Marshall JF (2019) Integrin-mediated TGFβ activation modulates the tumour microenvironment. Cancers (Basel) 11:1221. https://doi.org/10.3390/cancers11091221

Article  CAS  PubMed  Google Scholar 

Brown AB, Krug LM, Maslak P et al (2008) Pilot trial of a Wilms tumor-1 (WT1) peptide vaccine in patients with thoracic and myeloid neoplasms. J Clin Oncol 26(15_suppl):3051–3051. https://doi.org/10.1200/jco.2008.26.15_suppl.3051

Article  Google Scholar 

Buonaguro L, Tagliamonte M (2023) Peptide-based vaccine for cancer therapies. Front Immunol. https://doi.org/10.3389/fimmu.2023.1210044

Article  PubMed  PubMed Central  Google Scholar 

Burggraaf J, Kamerling IMC, Gordon PB et al (2015) Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met. Nat Med 21:955–961. https://doi.org/10.1038/nm.3641

Article  CAS  PubMed  Google Scholar 

Cai Y, Xu Z, Shuai Q et al (2020) Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery. Biomater Sci 8:2274–2282. https://doi.org/10.1039/C9BM02036E

Article  CAS  PubMed  Google Scholar 

Canesin G, Evans-Axelsson S, Hellsten R et al (2017) Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. PLoS One 12:e0184418. https://doi.org/10.1371/journal.pone.0184418

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capasso C, Magarkar A, Cervera-Carrascon V et al (2017) A novel in Silico framework to improve MHC-I epitopes and break the tolerance to melanoma. Oncoimmunology 6:e1319028. https://doi.org/10.1080/2162402X.2017.1319028

Article  PubMed  PubMed Central  Google Scholar 

Carvalho MR, Carvalho CR, Maia FR et al (2019) Peptide-modified dendrimer nanoparticles for targeted therapy of colorectal cancer. Adv Ther. https://doi.org/10.1002/adtp.201900132

Article  Google Scholar 

Cavallaro PA, De Santo M, Belsito EL et al (2023) Peptides targeting HER2-positive breast cancer cells and applications in tumor imaging and delivery of chemotherapeutics. Nanomaterials. https://doi.org/10.3390/nano13172476

Article  PubMed  PubMed Central  Google Scholar 

Chandarana C, Juwarwala I, Shetty S, Bose A (2024) Peptide drugs: current status and it’s applications in the treatment of various diseases. Curr Drug Res Rev 16:381–394. https://doi.org/10.2174/0125899775295960240406073630

Article  CAS  PubMed  Google Scholar 

Chang L, Perez A (2023) Ranking peptide binders by affinity with AlphaFold. Angew Chem Int Ed. https://doi.org/10.1002/anie.202213362

Article  Google Scholar 

Chang C-C, Liu D-Z, Lin S-Y et al (2008) Liposome encapsulation reduces cantharidin toxicity. Food Chem Toxicol 46:3116–3121. https://doi.org/10.1016/j.fct.2008.06.084

Article  CAS  PubMed  Google Scholar 

Chavakis T, Cines DB, Rhee J-S et al (2004) Regulation of neovascularization by human neutrophil peptides (α-defensins): a link between inflammation and angiogenesis. FASEB J 18:1306–1308. https://doi.org/10.1096/fj.03-1009fje

Article  CAS  PubMed  Google Scholar 

Chen X, Zaro JL, Shen W-C (2013) Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 65:1357–1369. https://doi.org/10.1016/j.addr.2012.09.039

Article